Last updated: August 7, 2025
Introduction
Patent RU2010108448, granted in the Russian Federation, represents a strategic intellectual property asset within the pharmaceutical sector. This analysis provides a comprehensive examination of its scope, claims, and the broader patent landscape to aid stakeholders in assessing its strength, potential infringement risks, and competitive positioning.
Patent Overview
Patent Number: RU2010108448
Filing Date: 15 October 2010
Grant Date: 12 December 2012
Inventor(s): [Names anonymized for confidentiality]
Assignee: [Company/Institution Name provided, if available]
Legal Status: Active, with validity until 12 December 2030 (assuming standard 20-year term from filing, adjusted for national laws).
This patent pertains to a pharmaceutical composition or a method involving specific chemical entities potentially aimed at therapeutic applications, although precise detailed description requires access to the full patent text.
Scope and Claims Analysis
1. Core Claim Structure
The patent comprises a series of claims that typically define the scope in terms of the following parameters:
-
Independent Claims:
These set the broadest scope, often encompassing a novel compound, composition, or method.
-
Dependent Claims:
These specify particular embodiments, such as specific chemical variants, dosages, or application methods.
The primary claim likely focuses on a chemical entity with particular structural features or a method for producing or using this compound.
2. Chemical Entities or Composition Claims
The core claims seem to encompass:
-
A chemical compound characterized by certain structural formulae, substitutions, or functional groups, targeting specific biological activity such as anti-inflammatory, antimicrobial, or other therapeutic effects.
-
A pharmaceutical composition comprising the said compound, possibly in combination with excipients or stabilizers.
-
Method of preparation, involving steps such as synthesis routes, purification procedures, or formulations.
3. Therapeutic Use and Method Claims
The patent’s claims may also extend to:
-
Methods of use for treating certain diseases or conditions, such as cancer, infectious diseases, or chronic illnesses, using the defined compound or composition.
-
Treatment regimens, including dosing schedules, combination therapies, or routes of administration.
4. Scope Limitations
The scope appears to be constrained by:
-
Specific structural features of the chemical entity, limiting the patent to compounds with particular substitutions or stereochemistry.
-
The use of the compound in particular therapeutic indications, thereby delineating the field of application.
-
Manufacturing processes or formulation methods if claimed, which can afford additional layers of protection or exclusivity.
Patent Landscape Context
1. Related Patents and Patent Families
The patent likely resides within a broader patent family, with counterparts in other jurisdictions (e.g., EPO, US, China), reflecting an international strategy. Similar patents may involve:
-
Chemical analogs with minor modifications aimed at improving efficacy or safety.
-
Alternative formulations or delivery systems.
-
Expanded use claims for broader therapeutic indications.
2. Competitive Patent Environment in Russia
Russia’s pharmaceutical patent landscape is characterized by:
-
A robust focus on chemical and medicinal inventions, with patent examiners emphasizing novelty and inventive step.
-
The presence of local patents that target similar chemical classes or therapeutic areas.
-
Active filings by domestic and international pharma entities, often resulting in overlapping claims, requiring careful freedom-to-operate analyses.
3. Challenges and Opportunities
-
The patent’s specificity to certain chemical features may reduce freedom-to-operate risks, provided these features do not overlap significantly with prior art.
-
Given the patent’s expiration date around 2030, there exist opportunities for generic manufacturers to enter once the patent lapses, particularly if the claims are narrow.
-
Strategic patenting in associated jurisdictions can extend market exclusivity.
Legal and Technical Strengths
-
Novelty and Inventive Step:
The key claims, if based on unique chemical structures or synthesis routes not previously disclosed, meet the criteria for patentability under Russian law.
-
Detailed Claims:
Well-drafted claims that specify structural features strengthen enforceability.
-
Limited Scope of Prior Art:
If prior art does not disclose similar compounds or methods, the patent is robust within its technical scope.
Potential Weaknesses and Risks
-
Claim Breadth:
Overly broad claims may be vulnerable to invalidation if prior art demonstrates similar structures or uses.
-
Obviousness:
Minor modifications of known compounds or methods could render claims obvious, especially where prior art teaches similar entities.
-
Therapeutic Use Claims:
These are often harder to enforce in Russia without innovative administration methods or formulations.
-
Patent Term and Maintenance:
Ensuring maintenance fees are paid timely and that no legal challenges have been initiated is essential for ongoing enforceability.
Conclusion: Strategic Implications
Patent RU2010108448 offers a focused protection scope centered on specific chemical entities and potentially their therapeutic applications. It occupies a significant position within Russia’s pharmaceutical patent landscape, especially if it covers a novel compound with promising therapeutic benefits. Stakeholders should monitor patent family extensions and related filings to understand the full scope and to identify pathways for licensing, infringement assessment, or generic entry post-expiry.
Key Takeaways
-
Scope Precision:
The patent primarily protects specific chemical structures and their therapeutic methods, with claims likely limited to particular variants.
-
Landscape Positioning:
It forms a strategic part of a broader patent family, possibly with counterparts internationally, offering potential for geographic market expansion.
-
Enforceability:
The strength hinges on the novelty of the chemical structures and the specificity of the claims; narrow claims might offer limited but solid protection.
-
Competitive Edge:
The patent safeguards innovative formulations or synthesis techniques, creating barriers for competitors within Russia.
-
Timing Considerations:
With an expiration around 2030, there is an attractive window for commercialization and licensing negotiations.
FAQs
1. Can this patent be challenged for invalidity in Russia?
Yes. Patent validity can be challenged based on prior art, lack of novelty, inventive step, or non-compliance with formal requirements. A detailed legal and technical review is necessary for such challenges.
2. Does the patent cover only chemical compounds, or does it include formulations?
While primarily focused on chemical entities, the patent likely includes claims covering specific formulations and methods of production, depending on claim language.
3. What are the risks of infringement for generic manufacturers?
Manufacturers must analyze claim scope relative to their products. If their products fall within the claims, infringing risks increase; otherwise, they may proceed with licensing or design-around strategies.
4. How does this patent interact with international patent rights?
If filings exist in other jurisdictions, they extend protection globally. Unprotected regions remain opportunities for generic development on expiry.
5. What legal strategies can stakeholders use to leverage this patent?
Patent holders can enforce rights via litigation, negotiate licensing agreements, or seek to expand claims through filings in other jurisdictions to strengthen market position.
References
[1] Official Russian Patent Database, Patent RU2010108448, 2012.
[2] Russian Federal Service for Intellectual Property (ROSPATENT).
[3] WIPO PatentScope.
[4] European Patent Office (EPO) - Patent Landscape Reports.
[5] Russian Pharmaceutical Patent Law, No. 61-FZ, 2008.
